{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:10:13Z","timestamp":1780697413080,"version":"3.54.1"},"reference-count":37,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1507\/endocrj.ej20-0823","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T22:10:02Z","timestamp":1625609402000},"page":"1391-1402","source":"Crossref","is-referenced-by-count":5,"title":["Prediction of new onset of diabetes mellitus during a 10-year period by using a combination of levels of alanine aminotransferase and \u03b3-glutamyl transferase"],"prefix":"10.1507","volume":"68","author":[{"given":"Daisuke","family":"Miyamori","sequence":"first","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"},{"name":"Tanaka Medical Clinic, Yoichi 046-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"},{"name":"Department of Public Health, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Koyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"},{"name":"Department of Public Health, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Osanami","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukimura","family":"Higashiura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Numata","sequence":"additional","affiliation":[{"name":"Department of Health Checkup and Promotion, Keijinkai Maruyama Clinic, Sapporo 064-0820, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hisasue","sequence":"additional","affiliation":[{"name":"Department of Health Checkup and Promotion, Keijinkai Maruyama Clinic, Sapporo 064-0820, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagisa","family":"Hanawa","sequence":"additional","affiliation":[{"name":"Department of Health Checkup and Promotion, Keijinkai Maruyama Clinic, Sapporo 064-0820, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Moniwa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, et al. (2019) Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9 th edition. Diabetes Res Clin Pract 157: 107843.","DOI":"10.1016\/j.diabres.2019.107843"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Moon AM, Singal AG, Tapper EB (2020) Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol 18: 2650\u20132666.","DOI":"10.1016\/j.cgh.2019.07.060"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, et al. (2007) How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 22: 788\u2013793.","DOI":"10.1111\/j.1440-1746.2007.05042.x"},{"key":"4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"4 Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, et al. (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64: 73\u201384.","journal-title":"Hepatology","ISSN":"https:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM (2013) Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev 34: 84\u2013129.","DOI":"10.1210\/er.2012-1009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH (2002) Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 17: 677\u2013681.","DOI":"10.1046\/j.1440-1746.2002.02755.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lidofsky SD (2008) Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment. Curr Diab Rep 8: 25\u201330.","DOI":"10.1007\/s11892-008-0006-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, et al. (2011) Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. J Hepatol 55: 435\u2013444.","DOI":"10.1016\/j.jhep.2010.10.039"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Zhang J, Cheng N, Ma Y, Li H, Cheng Z, et al. (2018) Liver enzymes, fatty liver and type 2 diabetes mellitus in a Jinchang Cohort: a prospective study in adults. Can J Diabetes 42: 652\u2013658.","DOI":"10.1016\/j.jcjd.2018.02.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kunutsor SK, Apekey TA, Walley J (2013) Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis. Am J Epidemiol 178: 159\u2013171.","DOI":"10.1093\/aje\/kws469"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kunutsor SK, Abbasi A, Adler AI (2014) Gamma-glutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response meta-analysis. Ann Epidemiol 24: 809\u2013816.","DOI":"10.1016\/j.annepidem.2014.09.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kim CH, Park JY, Lee KU, Kim JH, Kim HK (2009) Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver. Diabetes Metab Res Rev 25: 64\u201369.","DOI":"10.1002\/dmrr.890"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13 Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, et al. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 1889\u20131895.","DOI":"10.2337\/diabetes.51.6.1889"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kawaguchi T, Taniguchi E, Itou M, Sakata M, Sumie S, et al. (2011) Insulin resistance and chronic liver disease. World J Hepatol 3: 99\u2013107.","DOI":"10.4254\/wjh.v3.i5.99"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Stark AA, Zeiger E, Pagano DA (1993) Glutathione metabolism by gamma-glutamyltranspeptidase leads to lipid peroxidation: characterization of the system and relevance to hepatocarcinogenesis. Carcinogenesis 14: 183\u2013189.","DOI":"10.1093\/carcin\/14.2.183"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16 Lee DH, Jacobs DR Jr (2005) Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 178: 327\u2013330.","DOI":"10.1016\/j.atherosclerosis.2004.08.027"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Kaneko K, Yatsuya H, Li Y, Uemura M, Chiang C, et al. (2019) Association of gamma-glutamyl transferase and alanine aminotransferase with type 2 diabetes mellitus incidence in middle-aged Japanese men: 12-year follow up. J Diabetes Investig 10: 837\u2013845.","DOI":"10.1111\/jdi.12930"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18 Ford ES, Schulze MB, Bergmann MM, Thamer C, Joost HG, et al. (2008) Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes Care 31: 1138\u20131143.","DOI":"10.2337\/dc07-2159"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Higashiura Y, Tanaka M, Furuhashi M, Koyama M, Ohnishi H, et al. (2020) Low urine pH predicts new onset of diabetes mellitus during a 10-year period in men: BOREAS-DM1 study. J Diabetes Investig 11: 1490\u20131497.","DOI":"10.1111\/jdi.13284"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Mori K, Furuhashi M, Tanaka M, Numata K, Hisasue T, et al. (2021) U-shaped relationship between serum uric acid level and decline in renal function during a 10-year period in female subjects: BOREAS-CKD2. Hypertens Res 44: 107\u2013116.","DOI":"10.1038\/s41440-020-0532-z"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 American Diabetes Association (2017) 2. Classification and Diagnosis of Diabetes. Diabetes Care 40(suppl 1): S11\u2013S24.","DOI":"10.2337\/dc17-S005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982\u2013992.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","volume":"16","author":"EF Schisterman","year":"2005","unstructured":"23 Schisterman EF, Perkins NJ, Liu A, Bondell H (2005) Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 16: 73\u201381.","journal-title":"Epidemiology","ISSN":"https:\/\/id.crossref.org\/issn\/1044-3983","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"24 DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837\u2013845.","journal-title":"Biometrics","ISSN":"https:\/\/id.crossref.org\/issn\/0006-341X","issn-type":"print"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Pencina MJ, D\u2019Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11\u201321.","DOI":"10.1002\/sim.4085"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Ko SH, Baeg MK, Han KD, Ko SH, Ahn YB (2015) Increased liver markers are associated with higher risk of type 2 diabetes. World J Gastroenterol 21: 7478\u20137487.","DOI":"10.3748\/wjg.v21.i24.7478"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Wang YL, Koh WP, Yuan JM, Pan A (2016) Association between liver enzymes and incident type 2 diabetes in Singapore Chinese men and women. BMJ Open Diabetes Res Care 4: e000296.","DOI":"10.1136\/bmjdrc-2016-000296"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Hatano Y, Inoue K, Kashima S, Matsumoto M, Akimoto K (2020) Serum alanine transaminase as a predictor of type 2 diabetes incidence: the yuport prospective cohort study. Tohoku J Exp Med 251: 183\u2013191.","DOI":"10.1620\/tjem.251.183"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30 Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, et al. (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women\u2019s Heart and Health Study and meta-analysis. Diabetes Care 32: 741\u2013750.","DOI":"10.2337\/dc08-1870"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Furuhashi M, Matsumoto M, Tanaka M, Moniwa N, Murase T, et al. (2018) Plasma xanthine oxidoreductase activity as a novel biomarker of metabolic disorders in a general population. Circ J 82: 1892\u20131899.","DOI":"10.1253\/circj.CJ-18-0082"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Furuhashi M, Koyama M, Matsumoto M, Murase T, Nakamura T, et al. (2019) Annual change in plasma xanthine oxidoreductase activity is associated with changes in liver enzymes and body weight. Endocr J 66: 777\u2013786.","DOI":"10.1507\/endocrj.EJ19-0053"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Furuhashi M (2020) New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity. Am J Physiol Endocrinol Metab 319: E827\u2013E834.","DOI":"10.1152\/ajpendo.00378.2020"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Goldberg DM (1980) Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci 12: 1\u201358.","DOI":"10.3109\/10408368009108725"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Lee DH, Blomhoff R, Jacobs DR Jr (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38: 535\u2013539.","DOI":"10.1080\/10715760410001694026"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Ceriello A, Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24: 816\u2013823.","DOI":"10.1161\/01.ATV.0000122852.22604.78"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, et al. (2018) Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol 6: 69\u201380.","DOI":"10.1016\/S2213-8587(17)30186-9"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/12\/68_EJ20-0823\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:31:41Z","timestamp":1715142701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/68\/12\/68_EJ20-0823\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0823","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"EJ20-0823"}}